Our value-based agreements (VBAs) are built on partnerships; sharing risk and delivering value to payers and society. They are based on clinical performance and designed to help control costs while measuring the achievement of quality results from treatment.
We’ve offered VBAs since ONPATTRO, our first commercial approval.
Connect with an Alnylam Payer Account Lead to learn more
Payer Resources
Explore resources for the therapeutic areas Alnylam supports and other information that may be useful for payers.
General Resources
Learn more about RNAi discovery, how RNAi works, and features of RNAi therapeutics.
Access an annual report offering a unique lens into payer and plan decision-maker perspectives on the evolving dynamics of orphan drug access.
Explore personalized patient services to throughout treatment with an Alnylam product.
For US healthcare professionals to access educational, clinical, and scientific information about Alnylam's therapeutic areas and the science of RNAi behind our FDA-approved therapies and clinical pipeline.
You will be redirected to an external site that may include social media, event registration, or other third-party content related to Alnylam.
Please note that these external sites have their own terms of service and privacy policies, which may differ from those of Alnylam.
Proceed to Site